Top Markets
#1 Pleasing Gold Pleasing Gold +1,512.90%
#2 PulseChain PulseChain +58.12%
#3 Merlin's Seal BTC Merlin's Seal BTC +33.69%
#4 BOOK OF MEME BOOK OF MEME +31.60%
#5 Ontology Gas Ontology Gas +31.47%
#6 ConstitutionDAO ConstitutionDAO +25.51%
#7 Neiro Neiro +24.33%
#8 Unit Pump Unit Pump +22.47%
#9 Pump.fun Pump.fun +22.47%
#10 Collect on Fanable Collect on Fanable +21.07%
Coin of the day
Pleasing Gold Pleasing Gold
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Serina Therapeutics, Inc. Serina Therapeutics, Inc.

Serina Therapeutics, Inc.

SER
Rang in Aktien #26518
Serina Therapeutics, Inc., a biotechnology firm, focuses on creating... Serina Therapeutics, Inc., a biotechnology firm, focuses on creating pharmaceutical treatments for neurological conditions and pain. Its primary investigational drug, SER 252, is a POZ conjugate intended for managing Parkinson's disease. The company is also developing SER 227 for prolonged pain relief, SER 214, another candidate for Parkinson's disease, and SER 228 to treat epilepsy. Beyond these, Serina Therapeutics leverages its POZ technology in producing ribonucleic acid (RNA) vaccines delivered via lipid nanoparticles for combating infectious diseases. This company was established in 2006 and is headquartered in Huntsville, Alabama.
Aktienkurs
$2.67
Marktkapitalisierung
$39.97M
Veränderung (1 Tag)
-2.38%
Veränderung (1 Jahr)
-48.75%
Land
US
Handel Serina Therapeutics, Inc. (SER)

Kategorie

Healthcare
EPS für Serina Therapeutics, Inc. (SER)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von Serina Therapeutics, Inc. beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von Serina Therapeutics, Inc. von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $2.98 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US